Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Atrial Fibrillation and CYP2C19[original query] |
|---|
| Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. The New England journal of medicine 2010 Oct 363 (18): 1704-14. Paré Guillaume, Mehta Shamir R, Yusuf Salim, Anand Sonia S, Connolly Stuart J, Hirsh Jack, Simonsen Katy, Bhatt Deepak L, Fox Keith A A, Eikelboom John |
| Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm. Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
| Pharmacogenetics role in the safety of acenocoumarol therapy. Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
| Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation. Gene 2016 Jun . Zhang Hongshen, Ma Kezhong, Liu Wenwei, Yang Feng, Liu Jianfei, Zhou Hany |
| Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI. Experimental and therapeutic medicine 2018 9 16 (4): 3492-3496. Zhang Qifeng, Zhong Zhixiong, Li Bin, Liao Zhengxian, Zhao Pingsen, Ye Zhuolian, He Xuebo, Wang Hao, Chen Wenhao, Huang Junpi |
| Gene polymorphisms in dual antiplatelet therapy and the presence of hypo-attenuated leaflet thickening after transcatheter aortic valve replacement. Journal of thrombosis and thrombolysis 2018 Feb . Xiong Tian-Yuan, Liao Yan-Biao, Feng Yuan, Zhao Ming-Yue, Zhao Zhen-Gang, Li Yi-Jian, Liu Xiao-Jing, Chen M |
| Integrative Medicine on Optimizing Clopidogrel and Aspirin Therapy. Chinese journal of integrative medicine 2018 Jan . Chen H |
| CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
| CYP2C19 Loss-of-Function Associated with First-Time Ischemic Stroke in Non-surgical Asymptomatic Carotid Artery Stenosis During Clopidogrel Therapy. Translational stroke research 2021 2 13 (1): 46-55. Patel Pious D, Niu Xinnan, Shannon Chevis N, Denny Joshua C, Peterson Josh F, Fusco Matthew R, Chitale Rohan |
| Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
| Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy. Journal of thrombosis and thrombolysis 2023 3 . Berteotti M, Gori A M, Giusti B, Fortini A, Grossi G, Ciardetti N, Migliorini A, Lotti E, Valenti R, Di Mario C, Marchionni N, Marcucci |
- Page last reviewed:Feb 1, 2024
- Content source: